Eli Lilly launches TuneLab, an artificial intelligence platform providing biotechnology companies access to drug discovery models trained on over $1 billion worth of proprietary research data. The federated learning system enables smaller companies to utilise Lilly’s AI capabilities whilst preserving data privacy through third-party hosting.
Cambridge-based molecular diagnostics company Cyted Health has completed a $44 million Series B financing round to accelerate commercial expansion of its minimally invasive oesophageal cancer detection platform across the United States, following successful deployment of over 35,000 tests within the NHS.
Research Triangle Park, North Carolina, United States, has witnessed a significant consolidation of molecular testing and biospecimen storage services as Astoriom and Carolina Molecular announce a strategic partnership designed to address critical workflow challenges in clinical research operations.
German biomedical company ARTCLINE has closed a €5 million convertible loan financing round to complete its ongoing ReActIF-ICE clinical trial evaluating the ARTICE® extracorporeal therapy. The treatment uses allogeneic immune cells from healthy donors to support dysregulated immune systems in septic shock patients.
Researchers have developed CRISPR-GPT,an artificial intelligence system that can autonomously design and guide complete gene-editing experiments from start to finish. The multi-agent platform successfully orchestrated knockout experiments and epigenetic activation in human cell lines, marking a significant step towards AI-driven biological research automation.
Laboratory leaders worldwide are embracing digital pathology and artificial intelligence as essential tools to address mounting staffing shortages and financial pressures whilst advancing precision medicine initiatives. A comprehensive survey of 360 senior professionals reveals overwhelming confidence in AI-driven pathology’s readiness for clinical implementation.
Sartorius Stedim Biotech has secured exclusive global distribution rights for NanoSpark® immune cell activation reagents, investing up to US$3 million in Nanotein Technologies whilst establishing a joint development programme targeting enhanced T cell and NK cell manufacturing workflows for cellular therapy applications.
Biological reagent supplier Antibodies.com has made a strategic relocation to Cambridge Technopark, which reflects sustained global growth, with its customer base tripling over five years to serve over 5,000 research institutions worldwide across more than 100 countries.
Danish pharmaceutical giant Novo Nordisk has appointed Maziar Mike Doustdar as chief executive officer, bringing his proven track record of doubling international sales over the past decade. The leadership transition coincides with strategic R&D consolidation as the company positions itself to address rapidly developing diabetes and obesity markets.
Enhanced Genomics has partnered with Cambridge University’s ALBORADA Drug Discovery Institute to identify novel therapeutic targets for Alzheimer’s disease using advanced 3D multi-omics technology. The collaboration has already yielded multiple previously undetectable targets, potentially accelerating drug discovery timelines across neurodegenerative diseases.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
